HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Rubin Selected Research

Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

5/2005Molecular prostate cancer pathology: current issues and achievements.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Rubin Research Topics

Disease

15Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2002
11Neoplasms (Cancer)
12/2021 - 01/2002
3Adenocarcinoma
12/2021 - 07/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2014 - 04/2007
3Disease Progression
02/2014 - 06/2011
2Neoplasm Metastasis (Metastasis)
01/2020 - 06/2009
2Breast Neoplasms (Breast Cancer)
06/2011 - 11/2010
1Cerebral Hemorrhage
08/2022
1Ischemic Stroke
08/2022
1Inflammation (Inflammations)
02/2015
1Hemorrhagic Shock
02/2015
1Diarrhea
11/2013
1Malignant Pleural Effusion
11/2013
1Exanthema (Rash)
11/2013
1Esophageal Neoplasms (Esophageal Cancer)
07/2012
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011
1Neutropenia
04/2007
1Margins of Excision
12/2006
1Necrosis
03/2006
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2005
1Hypersensitivity (Allergy)
06/2003
1Dental Caries (Decay, Dental)
01/2002

Drug/Important Bio-Agent (IBA)

6Hormones (Hormone)IBA
01/2022 - 10/2007
5Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2002
5Bevacizumab (Avastin)FDA Link
09/2014 - 06/2011
4AndrogensIBA
12/2021 - 06/2009
4Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2014 - 09/2011
2AntigensIBA
01/2022 - 01/2017
2Docetaxel (Taxotere)FDA Link
01/2022 - 04/2007
2ErbB Receptors (EGF Receptor)IBA
09/2014 - 10/2007
2Biological ProductsIBA
02/2014 - 05/2005
2Carboplatin (JM8)FDA LinkGeneric
07/2012 - 09/2011
2Fluorouracil (Carac)FDA LinkGeneric
07/2012 - 09/2011
2Paclitaxel (Taxol)FDA LinkGeneric
07/2012 - 09/2011
2DNA (Deoxyribonucleic Acid)IBA
11/2011 - 11/2009
2Proteins (Proteins, Gene)FDA Link
06/2009 - 10/2002
1abirateroneIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1LigandsIBA
01/2022
1Long Noncoding RNAIBA
12/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2018
1Dihydrotestosterone (Androstanolone)IBA
01/2018
1Testosterone (Sustanon)FDA Link
01/2018
1Serine Proteases (Serine Protease)IBA
01/2017
1salicylhydroxamic acid (SHAM)IBA
02/2015
1Carbon MonoxideIBA
02/2015
1CytokinesIBA
02/2015
1Prostate-Specific Antigen (Semenogelase)IBA
10/2014
1Pharmaceutical PreparationsIBA
02/2014
1Estrogens (Estrogen)FDA Link
06/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2011
1Fulvestrant (Faslodex)FDA Link
06/2011
1Anastrozole (Arimidex)FDA LinkGeneric
06/2011
1Trastuzumab (Herceptin)FDA Link
11/2010
1Epidermal Growth Factor (EGF)IBA
11/2010
1vinflunineIBA
11/2010
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2009
1RNA (Ribonucleic Acid)IBA
11/2009
1DNA ProbesIBA
11/2009
1CaspasesIBA
06/2009
1Mitochondrial Proteins (Mitochondrial Protein)IBA
06/2009
1Gefitinib (Iressa)FDA Link
10/2007
1Dermal FillersIBA
03/2006
1CollagenIBA
06/2003
1Hyaluronic Acid (Hyaluronan)IBA
06/2003
1Complementary DNA (cDNA)IBA
10/2002
1rab GTP-Binding ProteinsIBA
10/2002
1FluoridesIBA
01/2002

Therapy/Procedure

12Therapeutics
01/2022 - 06/2009
4Castration
12/2021 - 02/2014
4Drug Therapy (Chemotherapy)
09/2014 - 09/2011
3Radiotherapy
01/2022 - 09/2011
1Thrombectomy
08/2022
1Precision Medicine
01/2021
1Resuscitation
02/2015
1Neoadjuvant Therapy
07/2012
1Induction Chemotherapy
09/2011
1Combined Modality Therapy
09/2011
1Lasers (Laser)
06/2009
1Prostatectomy (Retropubic Prostatectomy)
12/2006
1Fluoridation
01/2002